Thursday, May 23, 2013 Last update: 6:23 AM
Company Tech News as it Breaks

Iowa News

Wednesday, December 7, 2011

  • Posted at 2:59 PM
    Internet-based Attacks with Static Filtering, Stateful Packet Inspection and Threshold-Based Filtering West Des Moines, IA - ( December 7, 2011) – Icon Labs (www.iconlabs.com) a leading provider of embedded networking and security technology, today announced that UBM Electronics’ EDN has named their Floodgate-Packet Filter embedded firewall one of the “100 Hot Products of 2011.” The 2011 EDN Hot 100 highlights the electronics industry’s most significant products of the year based on innovation, significance, usefulness, and popularity. According to ... read more

Tuesday, May 21, 2013

  • Posted at 8:00 AM
    While winter's grip has finally released and we can enjoy the pleasures of spring, your divorcing friend may be in the midst of her own personal winter and the warmth of spring may seem beyond her reach. Alicia Klat, attorney and contributor to SupportinASplit.com, shares three examples of clients who have committed to exciting new lives post-divorce. Help your divorcing friend stay inspired and imagine a fulfilling life with these positive role models. (Photo: http://photos.prnewswire.com/prnh/20130521/CG17447) (Logo: http://photos.prnewswire.com/prnh/20130122/CG45741LOGO-b) Learn more about why good role ... read more

Friday, May 17, 2013

  • Posted at 11:04 AM
    Parents and kids have one more reason to celebrate this summer. Throughout the next few weeks, Box Tops for Education(®) coupons will become available on Yoplait(®) Frozen Yogurt treats. Yoplait Frozen Yogurt is joining forces with General Mills Box Tops for Education, a nationwide fundraising program dedicated to helping America's schools get the things they need. Each Box Tops for Education coupon collected provides 10 cents in unrestricted funding, helping mom turn her shopping list into books and basketballs, field trips ... read more

Wednesday, May 15, 2013

  • Posted at 9:27 AM
    Winnebago Industries, Inc. (NYSE:WGO), a leading U.S. manufacturer of recreation vehicles, has selected Rand McNally as its exclusive provider of mapping and routing services for its 2014 motorhomes. Rand McNally's award-winning RV GPS navigation will be featured as part of the new X1 family of infotainment systems from XiteSolutions North America, available in Winnebago, Itasca and Winnebago Touring Coach motorhomes. Winnebago Industries has chosen the new X1S 6" and the industry first, X1DM 10.4" Infotainment Systems. With a 10.4" display ... read more

Thursday, May 2, 2013

  • Posted at 1:15 PM
    Kevin D. Mowbray, vice president of publishing and publisher of the St. Louis Post-Dispatch, has been promoted to vice president and chief operating officer of Lee Enterprises, Incorporated (NYSE: LEE). Kevin D. Mowbray, Vice President and Chief Operating Officer of Lee Enterprises, Incorporated www.lee.net 05/02/2013 (Photo: Lee Enterprises) ... read more

Wednesday, May 1, 2013

  • Posted at 8:45 AM
    A report from the American Heart Association (AHA) published on April 22 concluded that the Transcendental Meditation (TM) technique lowers blood pressure and recommends that TM may be considered in clinical practice for the prevention and treatment of hypertension. The purpose of the report, entitled "Beyond Medications and Diet -- Alternative Approaches to Lowering Blood Pressure: A Scientific Statement From the American Heart Association," is to inform physicians which alternative approaches to lowering blood pressure have been shown by research ... read more

Thursday, April 25, 2013

  • Posted at 4:00 AM
    NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company primarily focused on discovering, developing and commercializing immunotherapeutic products in oncology, announced today that Nicholas N. Vahanian, M.D., NewLink's Chief Medical Officer, is scheduled to present at the Needham and Company 12th Annual Healthcare Conference in New York on Tuesday, April 30, 2013 at 12:50 p.m. ET. About NewLink Genetics Corporation NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve treatment options for cancer ... read more

Wednesday, April 24, 2013

  • Posted at 7:00 AM
    A new ARAG(®) study demonstrates a correlation between having a legal plan and decreased stress - a significant find if you are looking for ways to boost wellness and productivity. (Logo: http://photos.prnewswire.com/prnh/20130122/CG45741LOGO-b) "Medical experts have clearly established that stress puts people at risk for health problems and costs businesses billions of dollars due to absenteeism and lost productivity," said David Murray, President and CEO of ARAG, a global provider of legal solutions. "ARAG's new research confirms that legal plans reduce stress ... read more

Thursday, April 18, 2013

  • Posted at 5:00 AM
    The Board of Directors of Rockwell Collins (NYSE: COL) has declared a quarterly dividend of 30 cents per share on its common stock, payable June 3, 2013, to shareholders of record at the close of business on May 13, 2013. ... read more

Wednesday, April 17, 2013

  • Posted at 4:36 AM
    Chat Mobility joined forces with Nashville Recording Artist, Rachel Holder, this week to promote driving safety utilizing video and audio Public Service Announcements (PSAs). The No Texting & Driving campaign is a reminder for drivers to be safe, pay attention while driving, and not be distracted by texting or other activities that might take the focus off driving. While visiting local high schools throughout Iowa, Rachel asked students to join her and take the No Texting and Driving pledge. ... read more

Tuesday, April 16, 2013

  • Posted at 5:48 AM
    KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that it has completed tablet manufacturing activities as part of the clinical and commercial development program for KP201. The manufactured tablets are a fixed-dose combination of KemPharm's proprietary, non-toxic ligand attached to hydrocodone and 325 mg of acetaminophen. KP201 is KemPharm's lead clinical candidate in development for the treatment of acute moderate to moderately severe pain. KP201, which ... read more

Monday, April 15, 2013

Friday, April 12, 2013

  • Posted at 7:04 AM
    CIVCO Medical Solutions, the leading provider of comprehensive motion management solutions, will showcase trUpoint ARCH(TM), a new stereotactic radiosurgery solution, Protura(TM) Robotic Patient Positioning System, and the Universal Couchtop(TM) Long Extension, along with other disease site solutions at the 2(nd) ESTRO Forum, booth #5200 in Geneva, Switzerland, 19-23 April 2013. (Logo: http://photos.prnewswire.com/prnh/20110419/AQ85801LOGO) -- trUpoint ARCH - CIVCO's new SRS/SRT solution for head and brain disease sites provides clinicians a simple ... read more

Wednesday, April 10, 2013

  • Posted at 5:00 AM
    Banno, a provider of data-enriched Web and transaction marketing services for financial institutions, announced today that it launched 15 responsive design websites during the first quarter 2013. Mashable predicted that 2013 is the year of responsive web design, and Banno’s ... read more

Tuesday, April 9, 2013

  • AT&T 4G LTE Coming To Davenport This Summer --- DAVENPORT, Iowa, April 10, 2013
    Posted at 9:01 PM
    AT&T* plans to roll out 4G LTE in Davenport this summer, bringing customers the latest generation of wireless network technology and faster mobile Internet speeds from the nation's fastest 4G LTE network**. (Logo: http://photos.prnewswire.com/prnh/20120612/DA23287LOGO) Watch here to see several of the benefits AT&T 4G LTE provides. LTE technology is capable of delivering speeds faster than many other mobile Internet technologies***. Customers will be able to stream, download, upload and game faster than ever before on the latest 4G LTE-compatible smartphones, ... read more
  • Posted at 11:17 AM
    Rockwell Collins (NYSE: COL) Chairman and CEO Clay Jones will address Wells Fargo Securities 2013 Industrial and Construction Conference in New York, NY on May 8, 2013, at 10:15 a.m. Eastern Time. A live audio webcast and subsequent replay of Jones’ comments will be ... read more
  • Posted at 8:00 AM
    As the friend of someone who is getting divorced, you'll likely be the source of reason in a typically overwhelming situation. Lacey Noel, an attorney and contributor to SupportInaSplit.com, offers some practical options to help you help your friend stay focused on the light at the end of the tunnel. (Photo: http://photos.prnewswire.com/prnh/20130409/CG90842) (Logo: http://photos.prnewswire.com/prnh/20130122/CG45741LOGO-b) Instead of offering relationship advice to your friend, try to offer support in a more pragmatic way. One practical way you can help is to become familiar ... read more

Monday, April 8, 2013

  • Posted at 4:00 AM
    NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company primarily focused on discovering, developing and commercializing immunotherapeutic products in oncology, announced today that the company presented preclinical data for NLG919, a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, at the American Association for Cancer Research (AACR) 2013 annual meeting. These data demonstrate that NLG919 potently inhibits the IDO pathway in vitro and in cell based assays, is orally bioavailable and has a favorable pharmacologic and toxicity profile. NLG919 is the second pipeline ... read more

Wednesday, April 3, 2013

  • Posted at 6:17 AM
    KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent application entitled, "Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Use Thereof." KP201, recently designated by USAN as benzhydrocodone, is in development for the treatment of acute moderate to moderately ... read more

Tuesday, April 2, 2013

  • Posted at 4:00 AM
    NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the initiation of a double-blind, randomized, placebo-controlled Phase 2 clinical study of its first IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, indoximod, in patients with metastatic breast cancer. The Phase 2 clinical study will evaluate indoximod as a new approach to treating cancer by administering this novel IDO pathway inhibitor, designed to counteract a key mechanism by which tumors evade immune-mediated destruction, in combination with ... read more